InvestorsHub Logo

scottsmith

09/12/18 8:19 PM

#240687 RE: kfcyahoo #240685

Leo tells bald face lies in pr’s and filings and folks wonder why I question the term sheet.

“Their(IPIX) own words in the 3/15/18 pr, noted below:

"Company preparing for U.S. Food and Drug Administration (FDA) meeting to discuss Brilacidin-OM development plan.

In response to DaubersUP 9/12/18 post:

¨The fact they state they are REQUESTING AN END OF TRIAL MEETING in Sept with fda for OM means something. Why did they wait so long? And now is time?”

DaubersUP

09/12/18 9:32 PM

#240698 RE: kfcyahoo #240685

SS. That could be very different meetings. I think and end of phase meeting closes down and we get direction on next phase. Hoping for Priority Review.